1-(TERT-BUTOXYCARBONYL)-1H-INDAZOLE-5-CARBOXYLIC ACID, 95.0%, 250mg

[S(R)]-N-[(1S)-1-[3',5'-Bis(1,1-dimethylethyl)[1,1'-biphenyl]-2-yl]-2-(diphenylphosphino)ethyl]-2-methyl-2-propanesulfinamide, 95%, 25mg

tert-Butyl 4-amino-4-phenylpiperidine-1-carboxylate, 250mg

Isoquinoline-7-carboxylic acid, 95.0%, 10g

Etoricoxib>95.0%(HPLC)(T)200mg

2-imino-4-(1H-indol-3-yl)-7,7-dimethyl-5-oxo-3,4,5,6,7,8-hexahydro-2H-1-benzopyran-3-carbonitrile, 90%, 1g

N-(2',6'-DINETHYLPHENYL)-2-PIPERIDINECARBOXAMIDE HCL, 95.0%, 1g

N,N'-Methanediylidenebis(2,6-diisopropylaniline), 95.0%, 500g

2,5-Dioxopyrrolidin-1-yl 4-(1,2,2-triphenylvinyl)benzoate, 97%, 1g

Diethyl 2-(2-bromobenzyl)malonate, 97.0%, 5g

Pot en verre de 50 ml verre transparent mat GL 51 rond

Colonne HPLC NUCLEODUR® 300-5 C4 ec, 250 mm, 4,6 mm, 1 pièce(s)

Flacons d'échantillon ROTILABO® avec filetage court ND9, Verre transparent, avec espace d'étiquetage, 1,5 ml, 100 Pièce(s)